SPECT and SPECT-CT in Oncology – A Proliferation of Applications
A Joint ACNM/SNMMI Webinar
Twyla B. Bartel, DO, MBA, FACNM
Benjamin Franc, MD, MS, MBA, Stanford University School of Medicine
Farshad Moradi, MD, PhD, Stanford University School of Medicine
Guideo Davidzon, MD, MS, Stanford University School of Medicine
Carina Mari Aparici, MD, Stanford University School of Medicine
Valentia Ferri, PhD, Stanford University School of Medicine
This session highlights how improvements in SPECT and SPECT-CT imaging technology have facilitated the advancement of the use of SPECT in several oncology applications. Participants will learn about applications that take advantage of SPECT-CT for localization, such as treatment planning for I-131 therapy in thyroid cancer, as well as applications that take advantage of the high sensitivity of SPECT and rapid acquisition systems, such as routine tomographic whole-body bone imaging to evaluate for osseous metastatic disease. Finally, SPECT-based dosimetry applications in theranostics will be discussed.
1. Describe 3 ways in which CT data from SPECT-CT is used to improve the image or diagnostic accuracy of SPECT.
2. Discuss applications of SPECT-CT in oncology that take specific advantage of the modality’s characteristics of precise localization, high sensitivity, and high specificity.
3. Examine how SPECT – guided dosimetry can be implemented in theranostic applications.
CE/SAM Credit applications for physicians, pharmacists, physicists and technologists are pending.